April 2009 -    IceCure announces the first IceSense procedure in women in Europe.  The first patient suffering from Breast Fibroadenoma has been successfully treated in Prague University hospital.

July 2008 -    IceCure (formerly Arbel Medical) has appointed Hezi Himelfarb as CEO of the company.  Mr. Himelfarb has 30 years of experience in the medical device industry, having previously served as CEO of Remon Medical Technologies (acquired by Boston Scientific) and COO of Medtronic-InStent Israel.

June 2008 -    IceCure (formerly Arbel Medical) has completed a $4.5 million round of capital raising led by Giza Venture Capital Fund.

January 2008 -    IceCure (formerly Arbel Medical) receives FDA clearance for its IceSense™ product.

December 2005 -  Official statement recognizing the safety and effectiveness of Cryoablation for the treatment of Fibroadenoma, issued by the American Society of Breast Surgeons (ASBS).   Full Statement